The blockbuster drug Humira has been one of the world's top sellers for more than two decades. But thanks to some copycats, including one that'll be sold at entrepreneur Mark Cuban's online pharmacy, ...
If you’re one of the millions of Americans taking the prescription medication Humira, get ready to add the word biosimilars to your conversations with your doctor. Starting July 1, alternatives to the ...
Uncertainties remain about the real-world benefit of adalimumab biosimilars for psoriasis, limiting their widespread adoption. This analysis involving patients in the U.K. and Ireland provides ...
For the past couple of years, investors looked ahead to one particular thing with dread: AbbVie's (ABBV +0.59%) blockbuster immunology drug facing competition. After all, at its peak, Humira brought ...
Mark Cuban's Cost Plus Drug Company announced a partnership with Coherus BioSciences to offer customers a biosimilar of Humira. Humira, owned by AbbVie Inc, is one of the bestselling drugs of all time ...
MONTREAL, Feb. 20, 2019 /CNW/ - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that Health Canada has approved HUMIRA® (adalimumab) for the treatment of ...
HOUSTON (CN) - A woman who says she developed lymphoma from the Humira she took for arthritis can advance just one claim against drugmaker Abbot Laboratories, a federal judge ruled, throwing out an ...
As with other medications, Humira can interact with certain other drugs. It can also interact with some vaccines. An interaction occurs when one substance causes another substance to have a different ...
The arthritis drug Humira has been a blockbuster seller for more than two decades. Now, some copycats could end Humira's reign. The blockbuster drug Humira has been one of the world's top sellers for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback